Heterocycle derivatives as histone deacetylase (hdac)...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 403/12 (2006.01) A61K 31/417 (2006.01) A61K 31/4178 (2006.01) A61K 31/435 (2006.01) C07D 233/64 (2006.01) C07D 401/14 (2006.01)

Patent

CA 2590811

The present invention relates to compounds of formula (I), or pharmaceutically acceptable salts or tautomers thereof, which are inhibitors of histone deacetylase (HDAC). The compounds of the present invention are useful for treating cellular proliferative diseases, including cancer. Further, the compounds of the present invention are useful for treating neurodegenerative diseases, schizophrenia and stroke among other diseases.

La présente invention concerne des composés représentés par la formule (I) ou des sels pharmaceutiquement acceptables ou des tautomères de ceux-ci, lesquels composés sont des inhibiteurs d'histone désacétylase (HDAC). Les composés de la présente invention servent au traitement de maladies prolifératives cellulaires, telles que le cancer. Les composés de la présente invention servent également à traiter diverses autres maladies telles que des maladies neurodégénératives, la schizophrénie et l'accident vasculaire cérébral.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Heterocycle derivatives as histone deacetylase (hdac)... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocycle derivatives as histone deacetylase (hdac)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocycle derivatives as histone deacetylase (hdac)... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1526678

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.